SCHEMBL9717525

SCHEMBL9717525

CC/C(=C/c1ccc(OCCCC(=O)O)c(Cl)c1Cl)[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.41
TSHR P16473 4/20 0.39
RAB9A P51151 3/20 0.39
CYSLTR2 Q9NS75 1/20 0.39
CYSLTR1 Q9Y271 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.37
PPARG P37231 8/20 0.37
PPARA Q07869 2/20 0.37
TRPA1 O75762 1/20 0.37
FBP1 P09467 1/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.37
ABCC3 O15438 1/20 0.37
PLIN1 O60240 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
GSTA1 P08263 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9717532 1.00 FFAR4 (0.41) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9717519 1.00 FFAR4 (0.41) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9717590 0.96 CYSLTR2 (0.40) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9717583 0.96 CYSLTR2 (0.40) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9717589 0.96 CYSLTR2 (0.40) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9721410 0.95 CYSLTR2 (0.41) FFAR4CYSLTR2CYSLTR1PPARGPPARA
SCHEMBL9717485 0.95 CYSLTR2 (0.41) FFAR4CYSLTR2CYSLTR1PPARGPPARA
SCHEMBL9717491 0.95 CYSLTR2 (0.41) FFAR4CYSLTR2CYSLTR1PPARGPPARA
SCHEMBL9717559 0.94 LMNA (0.39) FFAR4TSHRRAB9ACYSLTR2CYSLTR1
SCHEMBL9717566 0.94 LMNA (0.39) FFAR4TSHRRAB9ACYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240256-B1 COMPOUNDS USEFUL IN TREATING SICKLE CELL ANEMIA MERCK & CO. INC. (US) 1992-04-29 EP disclosed
US-4751244-A NITROALKENYL CARBOXYLIC ACIDS MERCK & CO., INC. (US) 1988-06-14 US disclosed
EP-0240256-A2 Compounds useful in treating sickle cell anemia MERCK & CO. INC. (US) 1987-10-07 EP disclosed